BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Evaristo-Mendonça F, Sardella-Silva G, Kasai-Brunswick TH, Campos RMP, Domizi P, Santiago MF, de Melo Reis RA, Mendez-Otero R, Ribeiro-Resende VT, Pimentel-Coelho PM. Preconditioning of Rat Bone Marrow-Derived Mesenchymal Stromal Cells with Toll-Like Receptor Agonists. Stem Cells Int 2019;2019:7692973. [PMID: 31531025 DOI: 10.1155/2019/7692973] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Xing H, Li R, Qing Y, Ying B, Qin Y. Biomaterial-based osteoimmunomodulatory strategies via the TLR4-NF-κB signaling pathway: A review. Applied Materials Today 2021;22:100969. [DOI: 10.1016/j.apmt.2021.100969] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
2 Li R, Li Y, Dong X. Preconditioning mesenchymal stromal cells with flagellin enhances the anti‑inflammatory ability of their secretome against lipopolysaccharide‑induced acute lung injury. Mol Med Rep 2020;22:2753-66. [PMID: 32945411 DOI: 10.3892/mmr.2020.11380] [Reference Citation Analysis]
3 Evaristo-Mendonça F, Sardella-Silva G, Kasai-Brunswick TH, Campos RMP, Domizi P, Santiago MF, de Melo Reis RA, Mendez-Otero R, Ribeiro-Resende VT, Pimentel-Coelho PM. Erratum to "Preconditioning of Rat Bone Marrow-Derived Mesenchymal Stromal Cells with Toll-Like Receptor Agonists". Stem Cells Int 2020;2020:5857046. [PMID: 32904567 DOI: 10.1155/2020/5857046] [Reference Citation Analysis]